Lv3
220 积分 2024-11-18 加入
A demonstration of estimands and sensitivity analyses for time-to-deterioration of patient reported outcomes
2个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
4个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
4个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
4个月前
已完结
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
8个月前
已完结
HR+/HER-2-早期乳腺癌复发风险与临床管理专家共识（2025版）
8个月前
已完结
皖公网安备34019202002308
